Recurrent Carcinoma of Ovary
1 clinical trials · Condition
◉ Watch Recurrent Carcinoma of Ovary
| Record | Firm | Date |
|---|---|---|
| A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. (NCT05335993) | CanariaBio Inc. | 2022-07-25 |
Track Recurrent Carcinoma of Ovary automatically
Every clearance here is in the API, with alerts when new ones post.